Skip to main content
. 2023 Apr 14;14:1149874. doi: 10.3389/fimmu.2023.1149874

Figure 2.

Figure 2

Front (Left) and bottom (Right) views of the predicted 3-dimensional structure of the ozoralizumab-TNFα trimer complex. The TNFα trimer molecule is shown with the molecular surface of each TNFα monomer unit colored dark yellow, light yellow, and light gray, respectively. The framework of the anti-TNFα NANOBODY® and the framework of the anti-HSA NANOBODY® are colored green and white, respectively. The CDRs are defined according to the Kabat numbering scheme and colored orange (CDR 1 and 2) and red (CDR3), respectively, and the two linkers are colored dark gray.